KAZIA LAUNCHES NEW SCIENTIFIC ADVISORY BOARD COMPRISED OF WO

/PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce the launch of its...

Related Keywords

Australia , United States , Sydney , New South Wales , Dana Farber Cancer Institute , Massachusetts , Stanford University , California , Boston , Zurich , Züsz , Switzerland , Houston , Texas , San Francisco , American , Swiss , Karen Ferrante , Murray Brennan , Susang Komen , James Garner , Alan Olivero , Patrick Wen , Priscilla Brastianos , Oncology Division , University Of California , Genentech , Department Of Neurological Surgery , Md Anderson Cancer Center , Breast Cancer Research Foundation Award , Society For Neuro , Kazia Therapeutics Limited , Central Nervous System Metastasis Center At Massachusetts , Moonshot Program , Johns Hopkins School Of Medicine , Agents Selection Committee , Kazia Therapeutics , Dr John De Groot Is Division , Hospital Harvard Medical School , Swiss Federal Institute Of Technology , Prnewswire Kazia Therapeutics Limited , Genentech Inc , College Of St , Harvard Longwood Neurology Training Program , University Of London , American Association For Cancer Research , Head Of Research Operations , American Brain Tumor Association Joel Gingras Award , Oncology At Dana Farber Cancer Institute , Therapeutics Limited , Scientific Advisory Board , Professor Sir Murray Brennan , Professor Peter Gunning , Central Nervous System Metastasis Center , Massachusetts General Hospital , Johns Hopkins School , Massachusetts General , Central Nervous System Metastasis Clinic , Harvard Medical , Nextgen Star , American Association , Cancer Research , Damon Runyon Clinical Investigator Award , Career Catalyst Award , Anne Klibanski Award , John De Groot , Division Chief , Neuro Oncology Division , Neurological Surgery , Cancer Center , Senior Director , Discovery Chemistry , Research Operations , Swiss Federal Institute , Harvard Medical School , Dana Farber Cancer , Response Assessment , Working Group , Medical College , Neurologic Diseases , Orphan Drug Designation , Fast Track Designation , Rare Pediatric Disease Designation , Orphan Designation , Annual Report , Chief Executive Officer ,